Search…

Europacon Vision: The clinical trial approval of the Tropicamide Hydrochloride eye drops.

05/12/2025

Opconvis announcement, recently received the "Notice of Approval for Drug Clinical Trial" issued by the National Medical Products Administration, approving the company's "Methyl ergonovine hydrochloride eye drops" to conduct clinical trials.

Latest

2 m ago

Zejing Pharmaceuticals: In a phase II dose optimization clinical study of ZG006 monotherapy in patients with refractory advanced small cell lung cancer, the optimal response rates for the 10 mg Q2W group and the 30 mg Q2W group were 60.0% and 66.7%, respectively.

2 m ago

Tianfu (06868.HK) spent 2720 Hong Kong dollars on December 5 to repurchase 1000 shares.

3 m ago

Guangqisu: After research, it has been decided to add Xinjiang Jingnu New Energy Industry Development Co., Ltd.'s "Jingnu" brand and Xinjiang Dongfang Xiwang New Energy Co., Ltd.'s "Dongfang Xiwang" brand as registered brands for polycrystalline silicon futures. For the list of registered brands and specific factory locations, please see the attachment.

3 m ago

Baiying Holdings (08525.HK): The company's business operations are still running as usual in all major aspects.

4 m ago

The spot market for DRAM is overall stable, with some particles experiencing a slight decrease.

+852 - 60190728

Customer Support

Commercial Services